Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by ERICH M STURGIS and GUOJUN LI.
ERICH M STURGIS
Connection Strength
6.437
GUOJUN LI
  1. Molecular epidemiology of papillary thyroid cancer: in search of common genetic associations. Thyroid. 2009 Oct; 19(10):1031-4.
    View in: PubMed
    Score: 0.348
  2. The role of human papillomavirus in squamous carcinoma of the head and neck. Curr Oncol Rep. 2006 Mar; 8(2):130-9.
    View in: PubMed
    Score: 0.272
  3. Apoptotic variants as predictors of risk of oropharyngeal cancer recurrence after definitive radiotherapy. Int J Cancer. 2015 Nov 15; 137(10):2454-61.
    View in: PubMed
    Score: 0.130
  4. A functional variant at miRNA-122 binding site in IL-1a 3' UTR predicts risk and HPV-positive tumours of oropharyngeal cancer. Eur J Cancer. 2015 Jul; 51(11):1415-23.
    View in: PubMed
    Score: 0.129
  5. TNF-a promoter polymorphisms and risk of recurrence in patients with squamous cell carcinomas of the nonoropharynx. Int J Cancer. 2014 Oct 01; 135(7):1615-24.
    View in: PubMed
    Score: 0.118
  6. Genetic variants in TNF-a promoter are predictors of recurrence in patients with squamous cell carcinoma of oropharynx after definitive radiotherapy. Int J Cancer. 2014 Apr 15; 134(8):1907-15.
    View in: PubMed
    Score: 0.115
  7. Potentially functional variants of p14ARF are associated with HPV-positive oropharyngeal cancer patients and survival after definitive chemoradiotherapy. Carcinogenesis. 2014 Jan; 35(1):62-8.
    View in: PubMed
    Score: 0.115
  8. Association of tumor necrosis factor-alpha promoter variants with risk of HPV-associated oral squamous cell carcinoma. Mol Cancer. 2013 Jul 19; 12:80.
    View in: PubMed
    Score: 0.113
  9. Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers. Cancer. 2013 Jul 15; 119(14):2593-601.
    View in: PubMed
    Score: 0.111
  10. Genetic variants in p53-related genes confer susceptibility to second primary malignancy in patients with index squamous cell carcinoma of head and neck. Carcinogenesis. 2013 Jul; 34(7):1551-7.
    View in: PubMed
    Score: 0.111
  11. Variants in nucleotide excision repair core genes and susceptibility to recurrence of squamous cell carcinoma of the oropharynx. Int J Cancer. 2013 Aug 01; 133(3):695-704.
    View in: PubMed
    Score: 0.110
  12. Interleukin-10 promoter variants predict HPV-positive tumors and survival of squamous cell carcinoma of the oropharynx. FASEB J. 2013 Jun; 27(6):2496-503.
    View in: PubMed
    Score: 0.110
  13. MicroRNA variants increase the risk of HPV-associated squamous cell carcinoma of the oropharynx in never smokers. PLoS One. 2013; 8(2):e56622.
    View in: PubMed
    Score: 0.110
  14. Pre-microRNA variants predict HPV16-positive tumors and survival in patients with squamous cell carcinoma of the oropharynx. Cancer Lett. 2013 Apr 28; 330(2):233-40.
    View in: PubMed
    Score: 0.109
  15. Significance of MDM2 and P14 ARF polymorphisms in susceptibility to differentiated thyroid carcinoma. Surgery. 2013 May; 153(5):711-7.
    View in: PubMed
    Score: 0.109
  16. Genetic variation in MDM2 and p14ARF and susceptibility to salivary gland carcinoma. PLoS One. 2012; 7(11):e49361.
    View in: PubMed
    Score: 0.108
  17. An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer center: a staging system in need of repair. Cancer. 2013 Jan 01; 119(1):81-9.
    View in: PubMed
    Score: 0.105
  18. Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers. Head Neck. 2013 Jun; 35(6):794-9.
    View in: PubMed
    Score: 0.105
  19. Genetic variants of NOXA and MCL1 modify the risk of HPV16-associated squamous cell carcinoma of the head and neck. BMC Cancer. 2012 May 01; 12:159.
    View in: PubMed
    Score: 0.104
  20. Association of combined p73 and p53 genetic variants with tumor HPV16-positive oropharyngeal cancer. PLoS One. 2012; 7(4):e35522.
    View in: PubMed
    Score: 0.104
  21. Functional single-nucleotide polymorphisms in the BRCA1 gene and risk of salivary gland carcinoma. Oral Oncol. 2012 Sep; 48(9):842-7.
    View in: PubMed
    Score: 0.104
  22. Genetic variants of p27 and p21 as predictors for risk of second primary malignancy in patients with index squamous cell carcinoma of head and neck. Mol Cancer. 2012 Mar 26; 11:17.
    View in: PubMed
    Score: 0.103
  23. Neighborhood deprivation and clinical outcomes among head and neck cancer patients. Health Place. 2012 Jul; 18(4):861-8.
    View in: PubMed
    Score: 0.103
  24. Functional polymorphisms in the insulin-like binding protein-3 gene may modulate susceptibility to differentiated thyroid carcinoma in Caucasian Americans. Mol Carcinog. 2012 Oct; 51 Suppl 1:E158-67.
    View in: PubMed
    Score: 0.103
  25. Combined p53-related genetic variants together with HPV infection increase oral cancer risk. Int J Cancer. 2012 Aug 01; 131(3):E251-8.
    View in: PubMed
    Score: 0.101
  26. Association of BRCA1 functional single nucleotide polymorphisms with risk of differentiated thyroid carcinoma. Thyroid. 2012 Jan; 22(1):35-43.
    View in: PubMed
    Score: 0.101
  27. Genetic variants of a BH3-only pro-apoptotic gene, PUMA, and risk of HPV16-associated squamous cell carcinoma of the head and neck. Mol Carcinog. 2012 Oct; 51 Suppl 1:E54-64.
    View in: PubMed
    Score: 0.101
  28. Phase II trial of induction chemotherapy followed by surgery for squamous cell carcinoma of the oral tongue in young adults. Head Neck. 2012 Sep; 34(9):1255-62.
    View in: PubMed
    Score: 0.100
  29. Modifying effect of MDM4 variants on risk of HPV16-associated squamous cell carcinoma of oropharynx. Cancer. 2012 Mar 15; 118(6):1684-92.
    View in: PubMed
    Score: 0.099
  30. Family history of cancer and risk of sporadic differentiated thyroid carcinoma. Cancer. 2012 Mar 01; 118(5):1228-35.
    View in: PubMed
    Score: 0.099
  31. Genetic variants of the p53 and p73 genes jointly increase risk of second primary malignancies in patients after index squamous cell carcinoma of the head and neck. Cancer. 2012 Jan 15; 118(2):485-92.
    View in: PubMed
    Score: 0.098
  32. p14ARF genetic polymorphisms and susceptibility to second primary malignancy in patients with index squamous cell carcinoma of the head and neck. Cancer. 2011 Mar 15; 117(6):1227-35.
    View in: PubMed
    Score: 0.094
  33. Glutathione-S-transferase polymorphisms and complications of microvascular head and neck reconstruction. Arch Facial Plast Surg. 2010 Nov-Dec; 12(6):373-8.
    View in: PubMed
    Score: 0.094
  34. No evidence of sex-related survival disparities among head and neck cancer patients receiving similar multidisciplinary care: a matched-pair analysis. Clin Cancer Res. 2010 Oct 15; 16(20):5019-27.
    View in: PubMed
    Score: 0.094
  35. Human papillomavirus and WHO type I nasopharyngeal carcinoma. Laryngoscope. 2010 Oct; 120(10):1990-7.
    View in: PubMed
    Score: 0.093
  36. Human papillomavirus seropositivity synergizes with MDM2 variants to increase the risk of oral squamous cell carcinoma. Cancer Res. 2010 Sep 15; 70(18):7199-208.
    View in: PubMed
    Score: 0.093
  37. Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites. Head Neck. 2011 Jun; 33(6):847-55.
    View in: PubMed
    Score: 0.093
  38. FAS and FASLG genetic variants and risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 2010 Jun; 19(6):1484-91.
    View in: PubMed
    Score: 0.091
  39. Association of p53 codon 72 polymorphism with risk of second primary malignancy in patients with squamous cell carcinoma of the head and neck. Cancer. 2010 May 15; 116(10):2350-9.
    View in: PubMed
    Score: 0.091
  40. Association of TGF-beta1 genetic variants with HPV16-positive oropharyngeal cancer. Clin Cancer Res. 2010 Mar 01; 16(5):1416-22.
    View in: PubMed
    Score: 0.090
  41. Human papillomavirus & WHO type I nasopharyngeal carcinoma. Laryngoscope. 2010; 120 Suppl 4:S185.
    View in: PubMed
    Score: 0.089
  42. Genetic polymorphisms of p21 and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck. Carcinogenesis. 2010 Feb; 31(2):222-7.
    View in: PubMed
    Score: 0.088
  43. p73 G4C14-to-A4T14 polymorphism and risk of second primary malignancy after index squamous cell carcinoma of head and neck. Int J Cancer. 2009 Dec 01; 125(11):2660-5.
    View in: PubMed
    Score: 0.088
  44. Matched-pair analysis of race or ethnicity in outcomes of head and neck cancer patients receiving similar multidisciplinary care. Cancer Prev Res (Phila). 2009 Sep; 2(9):782-91.
    View in: PubMed
    Score: 0.087
  45. Glutathione S-transferase polymorphisms and risk of second primary malignancy after index squamous cell carcinoma of the head and neck. Cancer Prev Res (Phila). 2009 May; 2(5):432-9.
    View in: PubMed
    Score: 0.085
  46. Association of p73 G4C14-to-A4T14 polymorphism with human papillomavirus type 16 status in squamous cell carcinoma of the head and neck in non-Hispanic whites. Cancer. 2009 Apr 15; 115(8):1660-8.
    View in: PubMed
    Score: 0.084
  47. Nucleotide excision repair core gene polymorphisms and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neck. Carcinogenesis. 2009 Jun; 30(6):997-1002.
    View in: PubMed
    Score: 0.084
  48. GSTM1 and GSTT1 null polymorphisms and risk of salivary gland carcinoma. Int J Clin Exp Med. 2009; 2(1):68-75.
    View in: PubMed
    Score: 0.084
  49. Association of XRCC1 polymorphisms and risk of differentiated thyroid carcinoma: a case-control analysis. Thyroid. 2009 Feb; 19(2):129-35.
    View in: PubMed
    Score: 0.083
  50. p73 G4C14-to-A4T14 polymorphism and risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never smokers and never drinkers. Cancer. 2008 Dec 15; 113(12):3307-14.
    View in: PubMed
    Score: 0.082
  51. Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers. Carcinogenesis. 2008 Nov; 29(11):2120-5.
    View in: PubMed
    Score: 0.081
  52. Fas single nucleotide polymorphisms and risk of thyroid and salivary gland carcinomas: a case-control analysis. Head Neck. 2008 Mar; 30(3):297-305.
    View in: PubMed
    Score: 0.078
  53. p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers. Carcinogenesis. 2008 Apr; 29(4):875-9.
    View in: PubMed
    Score: 0.078
  54. Exploratory analysis of Fas gene polymorphisms in pediatric osteosarcoma patients. J Pediatr Hematol Oncol. 2007 Dec; 29(12):815-21.
    View in: PubMed
    Score: 0.077
  55. X-ray repair cross-complementing group 1 (XRCC1) single-nucleotide polymorphisms and the risk of salivary gland carcinomas. Cancer. 2007 Jul 15; 110(2):318-25.
    View in: PubMed
    Score: 0.075
  56. RET polymorphisms and haplotypes and risk of differentiated thyroid cancer. Laryngoscope. 2005 Jun; 115(6):1035-41.
    View in: PubMed
    Score: 0.065
  57. Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2005 Sep; 26(9):1596-602.
    View in: PubMed
    Score: 0.064
  58. CYP2E1 G1532C, NQO1 Pro187Ser, and CYP1B1 Val432Leu polymorphisms are not associated with risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 2005 Apr; 14(4):1034-6.
    View in: PubMed
    Score: 0.064
  59. Association between the V109G polymorphism of the p27 gene and the risk and progression of oral squamous cell carcinoma. Clin Cancer Res. 2004 Jun 15; 10(12 Pt 1):3996-4002.
    View in: PubMed
    Score: 0.060
  60. Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2004 Oct; 25(10):1911-6.
    View in: PubMed
    Score: 0.060
  61. Influence of smoking history on imaging characteristics among patients with human papillomavirus-positive oropharyngeal cancer: a blinded matched-pair analysis. J Comput Assist Tomogr. 2014 Sep-Oct; 38(5):667-73.
    View in: PubMed
    Score: 0.031
  62. Functional single nucleotide polymorphisms of the RASSF3 gene and susceptibility to squamous cell carcinoma of the head and neck. Eur J Cancer. 2014 Feb; 50(3):582-92.
    View in: PubMed
    Score: 0.029
  63. Telomere length in peripheral blood lymphocytes contributes to the development of HPV-associated oropharyngeal carcinoma. Cancer Res. 2013 Oct 01; 73(19):5996-6003.
    View in: PubMed
    Score: 0.028
  64. A functional variant at the miR-885-5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer. FASEB J. 2013 Apr; 27(4):1404-12.
    View in: PubMed
    Score: 0.027
  65. Combined effects of E2F1 and E2F2 polymorphisms on risk and early onset of squamous cell carcinoma of the head and neck. Mol Carcinog. 2012 Oct; 51 Suppl 1:E132-41.
    View in: PubMed
    Score: 0.026
  66. Telomere length and TERT functional polymorphisms are not associated with risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 2011 Dec; 20(12):2642-5.
    View in: PubMed
    Score: 0.025
  67. Polymorphisms of MDM4 and risk of squamous cell carcinoma of the head and neck. Pharmacogenet Genomics. 2011 Jul; 21(7):388-96.
    View in: PubMed
    Score: 0.025
  68. Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck. Mol Carcinog. 2011 Sep; 50(9):697-706.
    View in: PubMed
    Score: 0.024
  69. Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer. 2010 Oct 15; 116(20):4753-60.
    View in: PubMed
    Score: 0.023
  70. Genetic variations in TERT-CLPTM1L genes and risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2010 Nov; 31(11):1977-81.
    View in: PubMed
    Score: 0.023
  71. Recent advances in thyroid cancer. Curr Probl Surg. 2008 Mar; 45(3):156-250.
    View in: PubMed
    Score: 0.020
  72. Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 2007 Aug; 16(8):1633-8.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.